TrialJournal of neurology2019
Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis.
Benjamin Turner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
47 papers cite it
this paperpooled ittrialcites it
TrialJournal of neurology2019
Benjamin Turner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.